A Study of Inhaled AZD8630 in Adolescents with Asthma

Trial Identifier: D6830C00005
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: September 2025
Study Completion Date: September 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States of America, CA Bakersfield, CA, United States of America, 93301
United States of America, FL Miami Lakes, FL, United States of America, 33014
United States of America, LA Lafayette, LA, United States of America, 70508
United States of America, NC Raleigh, NC, United States of America, 27607
United States of America, OH Toledo, OH, United States of America, 43617
United States of America, OK Oklahoma City, OK, United States of America, 73120
United States of America, SC Spartanburg, SC, United States of America, 29303
United States of America, TX Boerne, TX, United States of America, 78006
United States of America, UT Salt Lake City, UT, United States of America, 84107